| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/02/1992 | CA2101337A1 Method of producing f(ab')2 fragments of immunoglobulins |
| 08/01/1992 | CA2060270A1 Generation of cd4 helper t cells with interleukin 2 and interleukin 4 from l-phenylalanine methyl ester treated human peripheral blood cells |
| 07/31/1992 | WO1992013557A1 Stabilized antibody fragments |
| 07/31/1992 | CA2098097A1 Stabilized antibody fragments |
| 07/30/1992 | WO1992012732A1 Live vaccine against colibacillosis |
| 07/30/1992 | CA2101550A1 Live vaccine against colibacillosis |
| 07/29/1992 | EP0496725A2 Complex containing coagulation factor IX |
| 07/29/1992 | EP0496579A2 Modified immunogens comprising an immunogen attached to one or more non-immunogenic polymers |
| 07/29/1992 | EP0496135A2 Cell free marek's disease virus vaccine |
| 07/29/1992 | EP0495971A1 Thrombocytopenia determination |
| 07/29/1992 | EP0495910A1 Production and use of human nm23 protein and antibodies therefor |
| 07/29/1992 | EP0495896A1 Vaccines for protecting against infections by hiv virus;process for producing the same and their use as diagnostic and immunotherapy means. |
| 07/29/1992 | EP0495893A1 Dopamine releasing protein |
| 07/29/1992 | EP0495811A1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
| 07/29/1992 | CN1063109A Improvements in and relating to hormones |
| 07/28/1992 | USRE34013 Immunization of poultry with virus |
| 07/28/1992 | US5134075 Antitumor agents |
| 07/28/1992 | US5133961 Immunology |
| 07/28/1992 | CA1305828C Synthetic peptides and use for diagnosis and vaccination for aids and arc |
| 07/28/1992 | CA1305667C Co-vaccination using non-o-carbohydrate side-chain gram-negative bacteria preparation |
| 07/28/1992 | CA1305665C Macromolecular platinum antitumor compounds |
| 07/25/1992 | WO1992012729A1 Monoclonal antibodies to elam-1 and their uses |
| 07/25/1992 | CA2100681A1 Monoclonal antibodies to elam-1 and their uses |
| 07/24/1992 | CA2058464A1 Induction of tolerance with modified immunogens |
| 07/23/1992 | WO1992012246A1 Nucleotidic sequences coding for the murine adrenergic beta 3 receiver and applications thereof |
| 07/23/1992 | WO1992012240A1 Interferon sensitive recombinant poxvirus vaccine |
| 07/23/1992 | WO1992012176A1 Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof |
| 07/23/1992 | WO1992011869A1 Non-depleting cd4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (iddm) |
| 07/23/1992 | WO1992011868A1 Protective malaria sporozoite surface protein immunogen and gene |
| 07/23/1992 | WO1992011859A1 Peptide-mediated hyposensitization of the human t cell response to dermatophagoides spp. (house dust mite) |
| 07/22/1992 | EP0495052A1 Allergens of alder pollen and applications thereof |
| 07/22/1992 | EP0495050A1 Granulocyte-inhibiting polypeptide |
| 07/22/1992 | EP0494998A1 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof |
| 07/22/1992 | EP0494904A1 Device for oral administration of an active principle for preventive treatment of caries in babies. |
| 07/22/1992 | EP0259324B1 Mastitis vaccine |
| 07/21/1992 | US5132413 Sugar chain |
| 07/21/1992 | US5132406 Method of producing immunoglobulin preparations for intravenous injection |
| 07/21/1992 | US5132287 Methods of treating disorders which cause conglutinin deficiency |
| 07/21/1992 | US5132205 High ph extraction composition and its use to determine a chlamydial, gonococcal or herpes antigen |
| 07/21/1992 | US5132109 Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof |
| 07/21/1992 | CA1305417C Stable formulations of ricin toxin a chain and of rta-immunoconjugates and stabilizer screening methods therefor |
| 07/21/1992 | CA1305416C Method of isolating ca 125 antigen |
| 07/19/1992 | WO1992013097A1 Hepatic growth factor receptor is the met proto-oncogene |
| 07/18/1992 | CA2100876A1 Anti-growth factor antibodies in the treatment of vascular stenosis |
| 07/15/1992 | EP0494825A1 Synthetic peptides, derived from HBc antigen of hepatitis B virus |
| 07/15/1992 | EP0494317A1 The retrovirus SIV cpz-ant and its uses |
| 07/15/1992 | EP0494265A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region |
| 07/15/1992 | EP0494228A1 Ribozymzusammensetzungen und deren verwendung |
| 07/15/1992 | EP0494224A1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
| 07/15/1992 | EP0494175A1 Compositions for cell adhesion inhibition and methods of use |
| 07/15/1992 | EP0494158A1 A recombinant birth control vaccine |
| 07/15/1992 | CN1062662A Making method of pork measles young |
| 07/15/1992 | CN1017451B Method for the preparation of vaccine |
| 07/14/1992 | US5130416 Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from plasmodium falciparum |
| 07/14/1992 | US5130337 Aging of proteins by reaction with glucose or other reducing sugar |
| 07/14/1992 | US5130324 2-alkylidene-aminoguanidines and methods of use therefor |
| 07/14/1992 | US5130297 Polypeptides for treatment of arthritis and diabetes |
| 07/14/1992 | US5130256 Analysis of cyst fluid on aminocarbohydrate column for cancer diagnosis |
| 07/14/1992 | US5130248 Genetic engineering |
| 07/14/1992 | US5130247 Expression of fusion protein of HIV envelope and HBsAG |
| 07/14/1992 | US5130233 Method for determining the β-subunit of human prolyl hydroxylase by radioimmunoassay to detect hepatic disease |
| 07/14/1992 | US5130129 Method for enhancing antibody transport through capillary barriers |
| 07/14/1992 | US5130128 Hyperimmunized against antigens found in honey |
| 07/14/1992 | US5130127 Human tumor therapy using beta (1-3) glucanlentinan and anti-tumor antibodies |
| 07/14/1992 | US5130116 Radiotherapeutic immunoconjugates labeled with iodine-125 |
| 07/14/1992 | CA1305081C Recombinant herpes simplex viruses, vaccines and methods |
| 07/14/1992 | CA1304996C Process to facilitate the formation of diosoms dispersed in an aqueous phase and to improve their stability and their encapsulation rate and corresponding aspersions |
| 07/12/1992 | WO1992012235A1 FLAGELLA-LESS $i(BORRELIA) |
| 07/12/1992 | WO1992011870A1 Method of preventing inflammatory damage |
| 07/12/1992 | WO1992011864A1 Method of detecting circulating antibody types using dried or lyophilized cells or cell-like material |
| 07/12/1992 | WO1992011853A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 07/12/1992 | CA2100351A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 07/12/1992 | CA2100244A1 Flagella-less borrelia |
| 07/12/1992 | CA2100084A1 Method of preventing inflammatory damage |
| 07/12/1992 | CA2075928A1 Method of detecting circulating antibody types using dried or lyophilized cells or cell-like material |
| 07/10/1992 | WO1992012247A1 Analogs of piscine lhrh |
| 07/10/1992 | CA2100057A1 Analogs of piscine lhrh |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/09/1992 | WO1992011370A2 Polypeptides derived from proteins of the hepatitis c virus |
| 07/09/1992 | WO1992011369A1 Hpv39 papillomavirus genome-derived dna sequences, their application to in vitro diagnosis and production of immunogenic compositions |
| 07/09/1992 | WO1992011368A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 07/09/1992 | WO1992011367A2 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
| 07/09/1992 | WO1992011366A1 Cloning and expression of a protein antigen of toxoplasma gondii |
| 07/09/1992 | WO1992011365A1 Liver enriched transcription factor |
| 07/09/1992 | WO1992011361A1 Improved vaccines |
| 07/09/1992 | WO1992011293A1 Method for immobilization of thiol compounds via activation of polymers, activated polymers, and products obtained by the method |
| 07/09/1992 | WO1992011292A1 Acellular vaccine |
| 07/09/1992 | WO1992011291A1 Vaccines based on hepatitis b surface antigen |
| 07/09/1992 | WO1992011281A1 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 07/09/1992 | WO1992011031A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS |
| 07/09/1992 | WO1992011028A1 Hiv reverse transcriptase vaccine |
| 07/09/1992 | WO1992011027A1 Two-phase system for the production and presentation of foreign antigens in hybrid live vaccines |
| 07/09/1992 | WO1992011026A1 Neuronal cholinergic differentiation factor |
| 07/09/1992 | WO1992011023A1 Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines |
| 07/09/1992 | WO1992010936A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 07/09/1992 | DE4139418A1 New DNA encoding squamous cell carcinoma antigen - allowing large scale antigen prodn. for use as diagnostic reagent or immunogen, also useful as hybridisation probe |
| 07/09/1992 | CA2098845A1 Cloning and expression of protein antigen of toxoplasma gondii |
| 07/09/1992 | CA2098733A1 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
| 07/09/1992 | CA2098719A1 Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines |
| 07/09/1992 | CA2098598A1 Adhesin-oligosaccharide conjugate vaccine for haemophilus influenzae |